[ad_1] Ingelheim, Germany and Armonk N.Y., November 28, 2023 – Today, Boehringer Ingelheim and IBM (NYSE:IBM) announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover…
Tag: Boehringer
Boehringer launches 81% discounted biosimilar of AbbVie’s Humira
[ad_1] The logo of German pharmaceutical company Boehringer Ingelheim is seen at its building in Shanghai, China February 1, 2019. REUTERS/Stringer/File Photo Acquire Licensing Rights Oct 2 (Reuters) – Germany’s…
Boehringer Ingelheim invests €350m in new biotech R&D facility
[ad_1] The new €350 million biotechnology R&D centre is Boehringer Ingelheim’s largest single investment in Germany to date. Credit: nitpicker / Shutterstock.com Boehringer Ingelheim has inaugurated its new Biologicals Development…